RESEARCH-USE BIOSIMILAR ANTIBODY
Domvanalimab
Monoclonal antibody · IgG1
Domvanalimab (AB154) is an anti-TIGIT humanized monoclonal antibody. Domvanalimab binds human TIGIT9 and blocks the TIGIT-CD155 interaction. Domvanalimab can be used for studies of non-small cell lung cancer and esophageal cancer.
TARGETTIGIT
YMonoclonal antibody
CATALOGSC-BS-615
CATALOG NUMBERSC-BS-615
MOLECULAR WEIGHTApprox. 145.12 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Domvanalimab (AB154) is an anti-TIGIT humanized monoclonal antibody. Domvanalimab binds human TIGIT9 and blocks the TIGIT-CD155 interaction. Domvanalimab can be used for studies of non-small cell lung cancer and esophageal cancer.
Domvanalimab is a recombinant research-use antibody directed against TIGIT.